Indirect Treatment Comparison of Riociguat Replacement Therapy and Selexipag Add-on Therapy in Patients With Pulmonary Arterial Hypertension: Results From a Systematic Review. [PDF]
An JE +10 more
europepmc +1 more source
Comparing bridging drug therapy approaches prior to balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension: a prospective analysis from the national UK CURATE registry. [PDF]
Li OM +12 more
europepmc +1 more source
Optimizing riociguat therapy for pulmonary hypertension: A systematic review and meta-analysis of dose variability, safety, and efficacy. [PDF]
Faizan MA +15 more
europepmc +1 more source
When Resources Define Operability After Pulmonary Endarterectomy. [PDF]
Berardo Cunha C +2 more
europepmc +1 more source
Effect of Once-Daily Macitentan 75 mg on the Pharmacokinetics of Sildenafil, Riociguat, or Rosuvastatin in Healthy Male Participants. [PDF]
Csonka D +5 more
europepmc +1 more source
Sepsis reporting signals associated with endothelin receptor antagonists and IFITM3-Centered interferon-responsive monocyte features: a pharmacovigilance and transcriptomic study. [PDF]
Cheng Z, Li J, Liu F.
europepmc +1 more source
Impact of pharmacological sGC stimulation with Riociguat in experimental models of liver disease regression. [PDF]
Bonitz K +19 more
europepmc +1 more source
Balloon Pulmonary Angioplasty for CTEPH: Emerging Evidence From China: Better Done Than Deferred. [PDF]
Dong W, Sun X, Cao Y.
europepmc +1 more source
Recurrent Pulmonary Embolism After Pulmonary Endarterectomy During Rivaroxaban Therapy in a Resource-Limited Setting. [PDF]
Batool A, Ansari MI, Lutfi IA, Mohsin M.
europepmc +1 more source
Long-Term Survival of Balloon Pulmonary Angioplasty for Inoperable Chronic Thromboembolic Pulmonary Hypertension: A Multicenter Study. [PDF]
Zhou YP +12 more
europepmc +1 more source

